|
⚲
|
| Keyboard |
| New Mountain Capital LLC
✚
|
|
|---|---|
| CRD # | 161394 |
| SEC # | 801-74051 |
| CIK # | 0001407718 |
| AUM | 46.41 B (2026-03-30) |
| Employees | 235 (66% Investors, 3% Brokers) |
| Phone | 212-720-0300 |
| Address | 1633 Broadway New York, NY 10019 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Wed, 01 Jul 2026 | Ropes & Gray Advised New Mountain Capital in Majority Investment in SAM — Ropes & Gray LLP |
| Wed, 01 Jul 2026 | New Mountain Capital Partners with SAM, Leading Geospatial and Inspection Solutions Company, for Next Phase of Growth — Business Wire |
| Thu, 04 Jun 2026 | New Mountain Capital Buying Property Management Firm for $2B — The Real Deal |
| Fri, 22 May 2026 | BMI and New Mountain Capital Celebrated a Night of Music and Giving at Radio City Music Hall in New York City — bmi.com |
| Mon, 13 Apr 2026 | Novacore Launches New Mountain Capital-Backed Sidecar to Expand Specialty Program Capacity — PR Newswire |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Avantor Inc | 0.1 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | New Mountain SRC Continuation Fund LP | [2026-03-30] | 2,259.1 M | |
| Filed 2025-04-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $2,500,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain SRC Rollover Fund LP | [2026-03-30] | 405.4 M | |
| Filed 2025-04-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | New Mountain Strategic Equity Fund II LP | [2026-03-30] | 532.1 M | 178.1 M |
| Filed 2025-05-08 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $10,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners VII LP | [2025-03-27] | 15.43 B | 6,070.0 M |
| Offered $15,425,315,000 · Filed 2024-08-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Commission $49,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners VII Luxembourg SCSP | [2025-03-27] | 15.43 B | 916.3 M |
| Offered $15,425,315,000 · Filed 2024-08-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Commission $14,750,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain DAT Continuation Fund LP | [2024-03-26] | 2,542.6 M | |
| Filed 2023-11-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $6,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain DAT Rollover Fund LP | [2024-03-26] | 148.7 M | |
| Filed 2023-11-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | New Mountain CAS Continuation Fund LP | [2022-03-30] | 698.3 M | |
| Filed 2021-08-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners VI Luxembourg SCSP | [2021-03-30] | 7,753.1 M | 592.1 M |
| Filed 2020-09-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $5,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners VI LP | [2020-03-27] | 7,753.1 M | 13.38 B |
| Filed 2020-09-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $5,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain Strategic Equity Fund I LP | [2019-03-28] | 337.2 M | 992.9 M |
| Filed 2020-04-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $4,000,000 · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners V LP | [2018-03-29] | 5,850.0 M | 2,427.9 M |
| Offered $5,850,000,000 · Filed 2017-11-13 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Commission $14,065,625 · Revenue Decline to Disclose | ||||
| PE | New Mountain Partners IV LP | [2014-03-31] | 3,053.8 M | 431.9 M |
| Offered $4,000,000,000 · Filed 2014-07-09 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $946,224,600 · Duration More than one year · Commission $28,000,000 · Revenue Decline to Disclose | ||||
| PE | Allegheny New Mountain Partners LP | 2012-02-14 | 1.6 M | |
| PE | New Mountain Affiliated Investors II LP | 2012-02-14 | 0.4 M | |
| PE | New Mountain Affiliated Investors LP | 2012-02-14 | ||
| PE | New Mountain Partners III LP | [2012-02-14] | 195.6 M | |
| PE | New Mountain Partners II LP | 2012-02-14 | 20.5 M | |
| PE | New Mountain Partners LP | 2012-02-14 | ||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 14 | 46.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 14 | 46.4 |
| By Discretionary | ||
| Discretionary | 14 | 46.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 14 | 46.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.9 | |
| United States Persons | 43.5 | |
| Total | 14 | 46.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Simon Barnes | Director | 78 | 14 | |
| Jens Hoellermann | Director | 60 | 10 | |
| Adam Weinstein | Executive Officer | 116 | 4 | |
| Steven Klinsky | Executive Officer | 53 | 4 | |
| Georgios Bagkalas | Director | 3 | 2 | |
| New Mountain Investments III Continuation GP LLC | Promoter | 2 | 2 | |
| Usman Khattak | Director | 2 | 2 | |
| New Mountain Investments V LLC | Promoter | 2 | 1 | |
| New Mountain Investments IV LLC | Promoter | 2 | 1 | |
| New Mountain Investments IV Continuation GP LLC | Promoter | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001407718] | |
| 13F-NT | [0001407718] | |
| 3 | [0001407718] | |
| 4 | [0001407718] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $8.9B |
| Serves | Institutional |
| Fund Types | Private Equity |
| LEI | 549300SLP13FRRDC1A23 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
R1 RCM Inc /de RCM
Common Stock
|
2024-11-19 | Other | 124,910,408 | $14.30 | 1,786,218,834 |
|
R1 RCM Inc /de RCM
Common Stock
|
2024-11-19 | Other | 11,075,180 | $14.30 | 158,375,074 |
|
R1 RCM Inc /de RCM
Common Stock
|
2022-10-26 | Other | 9,454 | ||
|
R1 RCM Inc /de RCM
Common Stock
|
2022-10-26 | Other | 46,392 | ||
|
Signify Health Inc SGFY
Class A Common Stock
|
2022-05-19 | Grant | 44,016 | $0.00 | |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2021-03-18 | Sell | 400,000 | $5.48 | 2,192,000 |
|
Signify Health Inc SGFY
Class A Common Stock
|
2021-02-16 | Grant | 23,748 | $0.00 | |
|
Signify Health Inc SGFY
Class A Common Stock
|
2021-02-12 | Grant | 48,378,865 | $0.00 | |
|
Signify Health Inc SGFY
Class B Common Stock
|
2021-02-12 | Grant | 42,905,113 | $0.01 | 429,051 |
|
Signify Health Inc SGFY
Class A Common Stock
|
2021-02-12 | Grant | 48,330,828 | $0.00 | |
|
Signify Health Inc SGFY
LLC Units in Cure TopCo, LLC · derivative
|
2021-02-12 | Grant | 42,905,113 | $0.00 | |
|
Avantor Inc AVTR
Common Stock
|
2020-11-10 | Sell | 36,016,093 | $24.81 | 893,559,267 |
|
Avantor Inc AVTR
Common Stock
|
2020-08-21 | Sell | 25,575,472 | $19.51 | 498,977,459 |
|
Avantor Inc AVTR
Common Stock
|
2020-05-26 | Sell | 20,886,424 | $15.90 | 332,094,142 |
|
Avantor Inc AVTR
Common Stock
|
2019-05-21 | Sell | 100 | $14.00 | 1,400 |
|
Bellerophon Therapeutics LLC BLPH
Common Stock
|
2015-02-19 | Buy | 1,070,166 | $12.00 | 12,841,992 |
| Related Firms | State | AUM |
|---|---|---|
|
New Mountain Capital LLC
✚
|
NY | 46.41 B |
|
New Mountain Finance Advisers BDC LLC
✚
|
NY | |
|
New Mountain Finance Corporation
✚
|
NY | |
|
New Mountain Vantage Advisers LLC
✚
|
NY |
| Comparable Firms | State | AUM |
|---|---|---|
|
SB Investment Advisers US Inc
✚
|
CA | 53.47 B |
|
Capital International Inc
✚
|
CA | 51.92 B |
|
Genstar Capital Management LLC
✚
|
CA | 51.26 B |
|
GTCR LLC
✚
|
IL | 48.64 B |
|
Francisco Partners Management LP
✚
|
CA | 47.05 B |
|
AlpInvest Partners BV
✚
|
39.88 B | |
|
Members Capital Advisors Inc
✚
|
WI | 39.46 B |
|
Copenhagen Infrastructure Partners Inc
✚
|
NY | 39.35 B |
|
Mason Street Advisors LLC
✚
|
WI | 39.08 B |
|
MS Capital Partners Adviser Inc
✚
|
NY | 38.76 B |